Startup companies
fromSilicon Canals
3 months agoAmsterdam's Avidicure exits stealth mode with 43.8M to develop new antibody therapies - Silicon Canals
Avidicure launched with $50M funding to develop multifunctional antibodies for cancer treatment, aiming to revolutionize oncology with innovative therapies.